Methyldopa
Aldoclor, Aldomet, Aldoril (methyldopa) is a small molecule pharmaceutical. Methyldopa was first approved as Aldoclor-150 on 1982-01-01. It is used to treat hypertension in the USA. It is known to target aromatic-L-amino-acid decarboxylase.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
cardiovascular diseases | D002318 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chlorothiazide
+
Methyldopa
Hydrochlorothiazide
+
Methyldopa
Methyldopa
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
METHYLDOPA | Chartwell Pharmaceuticals | N-018934 RX | 1984-06-29 | 2 products, RS |
Show 2 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
methyldopa | New Drug Application | 2023-01-04 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hypertension | EFO_0000537 | D006973 | I10 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
— C02: Antihypertensives
— C02A: Antiadrenergic agents, centrally acting
— C02AB: Methyldopa, centrally acting adntiadrenergic agents
— C02AB01: Methyldopa (levorotatory)
— C02AB02: Methyldopa (racemic)
— C02L: Antihypertensives and diuretics in combination
— C02LB: Methyldopa and diuretics in combination
— C02LB01: Methyldopa (levorotatory) and diuretics
HCPCS
Code | Description |
---|---|
J0210 | Injection, methyldopate hcl, up to 250 mg |
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | 1 | 1 | 2 |
Femoral fractures | D005264 | S72 | — | — | — | 1 | — | 1 | |
Osteonecrosis | D010020 | EFO_0004259 | M87 | — | — | — | 1 | — | 1 |
Congenital hip dislocation | D006618 | HP_0001385 | Q65.2 | — | — | — | 1 | — | 1 |
Slipped capital femoral epiphyses | D060048 | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
Rheumatic diseases | D012216 | M79.0 | — | — | — | — | 1 | 1 | |
Joint diseases | D007592 | HP_0003040 | M12.9 | — | — | — | — | 1 | 1 |
Musculoskeletal diseases | D009140 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | METHYLDOPA |
INN | methyldopa |
Description | Alpha-methyl-L-dopa is a derivative of L-tyrosine having a methyl group at the alpha-position and an additional hydroxy group at the 3-position on the phenyl ring. It has a role as a hapten, an antihypertensive agent, an alpha-adrenergic agonist, a peripheral nervous system drug and a sympatholytic agent. It is a L-tyrosine derivative and a non-proteinogenic L-alpha-amino acid. |
Classification | Small molecule |
Drug class | dopamine receptor agonists |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O |
Identifiers
PDB | — |
CAS-ID | 555-30-6 |
RxCUI | 1545996 |
ChEMBL ID | CHEMBL459 |
ChEBI ID | 61058 |
PubChem CID | 38853 |
DrugBank | DB00968 |
UNII ID | M4R0H12F6M (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
DDC
DDC
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 5,835 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
14 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more